Xylem (NYSE:XYL) Stock Price Expected to Rise, TD Cowen Analyst Says

Xylem (NYSE:XYL) had its price objective increased by research analysts at TD Cowen from $130.00 to $135.00 in a report released on Friday,Benzinga reports. The firm currently has a “hold” rating on the industrial products company’s stock. TD Cowen’s target price points to a potential downside of 2.89% from the company’s previous close.

A number of other research firms have also commented on XYL. Mizuho set a $160.00 price objective on shares of Xylem in a research report on Wednesday, October 29th. Citigroup boosted their price objective on shares of Xylem from $173.00 to $182.00 and gave the stock a “buy” rating in a report on Wednesday, October 29th. Royal Bank Of Canada boosted their price objective on Xylem from $169.00 to $176.00 and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Robert W. Baird set a $178.00 price target on Xylem in a research report on Wednesday, October 29th. Finally, Weiss Ratings reissued a “buy (b)” rating on shares of Xylem in a research note on Monday, December 1st. Eight investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $167.40.

Xylem Trading Down 1.3%

Shares of Xylem stock opened at $139.01 on Friday. The company has a current ratio of 1.96, a quick ratio of 1.50 and a debt-to-equity ratio of 0.17. The stock has a fifty day simple moving average of $145.86 and a 200 day simple moving average of $138.59. Xylem has a 12-month low of $100.47 and a 12-month high of $154.27. The company has a market capitalization of $33.85 billion, a P/E ratio of 35.74, a price-to-earnings-growth ratio of 2.16 and a beta of 1.18.

Xylem (NYSE:XYL) last issued its quarterly earnings data on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.23 by $0.14. The business had revenue of $2.27 billion during the quarter, compared to the consensus estimate of $2.22 billion. Xylem had a net margin of 10.66% and a return on equity of 10.77%. The firm’s quarterly revenue was up 7.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $1.11 EPS. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. On average, sell-side analysts anticipate that Xylem will post 4.65 earnings per share for the current fiscal year.

Insider Buying and Selling at Xylem

In related news, EVP Claudia S. Toussaint sold 10,421 shares of Xylem stock in a transaction on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the transaction, the executive vice president directly owned 31,250 shares in the company, valued at approximately $4,770,000. The trade was a 25.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Victoria D. Harker sold 1,700 shares of the stock in a transaction that occurred on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director directly owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 0.27% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently made changes to their positions in the stock. Avantax Advisory Services Inc. lifted its position in shares of Xylem by 28.7% during the first quarter. Avantax Advisory Services Inc. now owns 3,049 shares of the industrial products company’s stock worth $364,000 after purchasing an additional 680 shares during the last quarter. XTX Topco Ltd bought a new position in Xylem in the first quarter worth about $321,000. Atria Wealth Solutions Inc. purchased a new stake in Xylem during the first quarter valued at approximately $886,000. Vanguard Group Inc. grew its holdings in Xylem by 1.3% in the first quarter. Vanguard Group Inc. now owns 29,006,544 shares of the industrial products company’s stock worth $3,465,122,000 after purchasing an additional 362,127 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. grew its stake in Xylem by 2.2% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,418,719 shares of the industrial products company’s stock worth $169,480,000 after buying an additional 30,608 shares during the last quarter. Institutional investors own 87.96% of the company’s stock.

Xylem Company Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.